These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11477319)

  • 21. Comparative stereoselective pharmacokinetic analysis of 10-hydroxycarbazepine after oral administration of its individual enantiomers and the racemic mixture to dogs.
    Volosov A; Yagen B; Bialer M
    Epilepsia; 2000 Sep; 41(9):1107-11. PubMed ID: 10999549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of the monohydroxy derivative of oxcarbazepine and its enantiomers after a single intravenous dose given as racemate compared with a single oral dose of oxcarbazepine.
    Flesch G; Czendlik C; Renard D; Lloyd P
    Drug Metab Dispos; 2011 Jun; 39(6):1103-10. PubMed ID: 21389120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Population pharmacokinetic analysis for 10-monohydroxy derivative of oxcarbazepine in pediatric epileptic patients shows no difference between Japanese and other ethnicities.
    Sugiyama I; Bouillon T; Yamaguchi M; Suzuki H; Hirota T; Fink M
    Drug Metab Pharmacokinet; 2015 Apr; 30(2):160-7. PubMed ID: 25989891
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of plasma and saliva concentrations of the active monohydroxy metabolite of oxcarbazepine in patients at steady state.
    Cardot JM; Degen P; Flesch G; Menge P; Dieterle W
    Biopharm Drug Dispos; 1995 Oct; 16(7):603-14. PubMed ID: 8785383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stereoselective pharmacokinetic analysis of the antiepileptic 10-hydroxycarbazepine in dogs.
    Volosov A; Sintov A; Bialer M
    Ther Drug Monit; 1999 Apr; 21(2):219-23. PubMed ID: 10217343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hydroxycarbazepine distribution in three postmortem cases.
    Levine B; Green-Johnson D; Moore KA; Fowler DR
    J Anal Toxicol; 2004 Sep; 28(6):509-11. PubMed ID: 15516305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug monitoring of lamotrigine and oxcarbazepine combination during pregnancy.
    Wegner I; Edelbroek P; de Haan GJ; Lindhout D; Sander JW
    Epilepsia; 2010 Dec; 51(12):2500-2. PubMed ID: 21204816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of pharmacokinetic interaction between oxcarbazepine and lamotrigine.
    Theis JG; Sidhu J; Palmer J; Job S; Bullman J; Ascher J
    Neuropsychopharmacology; 2005 Dec; 30(12):2269-74. PubMed ID: 16052246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does oxcarbazepine warrant therapeutic drug monitoring? A critical review.
    Bring P; Ensom MH
    Clin Pharmacokinet; 2008; 47(12):767-78. PubMed ID: 19026033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oxcarbazepine disposition: preliminary observations in patients.
    Kumps A; Wurth C
    Biopharm Drug Dispos; 1990; 11(4):365-70. PubMed ID: 2340349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma level monitoring of oxcarbazepine in epileptic patients.
    González-Esquivel DF; Ortega-Gavilán M; Alcántara-López G; Jung-Cook H
    Arch Med Res; 2000; 31(2):202-5. PubMed ID: 10880728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy, tolerability, and pharmacokinetics of oxcarbazepine oral loading in patients with epilepsy.
    Kim DW; Gu N; Jang IJ; Chu K; Yu KS; Cho JY; Yoon SH; Kim HS; Oh J; Lee SK
    Epilepsia; 2012 Jan; 53(1):e9-12. PubMed ID: 22091603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Therapeutic drug monitoring of oxcarbazepine].
    Bouquié R; Dailly E; Bentué-Ferrer D;
    Therapie; 2010; 65(1):61-5. PubMed ID: 20205998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of the antidepressant drug viloxazine on oxcarbazepine and its hydroxylated metabolites in patients with epilepsy.
    Pisani F; Fazio A; Oteri G; Artesi C; Xiao B; Perucca E; Di Perri R
    Acta Neurol Scand; 1994 Aug; 90(2):130-2. PubMed ID: 7801739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetic drug interactions in children taking oxcarbazepine.
    Sallas WM; Milosavljev S; D'souza J; Hossain M
    Clin Pharmacol Ther; 2003 Aug; 74(2):138-49. PubMed ID: 12891224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantification of oxcarbazeipine and its active metabolite 10-hydroxycarbazepine in human plasma by high-performance liquid chromatography.
    Nirogi RV; Kandikere VN; Shukla M; Mudigonda K; Ajjala DR
    Arzneimittelforschung; 2006; 56(7):517-23. PubMed ID: 16927533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carbamazepine extended-release capsules vs. oxcarbazepine: computer simulations of the effect of missed doses on drug plasma concentrations.
    Ahmad A; Garnett WR
    Curr Med Res Opin; 2005 Sep; 21(9):1363-8. PubMed ID: 16197654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The influence of food on the disposition of the antiepileptic oxcarbazepine and its major metabolites in healthy volunteers.
    Degen PH; Flesch G; Cardot JM; Czendlik C; Dieterle W
    Biopharm Drug Dispos; 1994 Aug; 15(6):519-26. PubMed ID: 7993989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. First dose and steady-state pharmacokinetics of oxcarbazepine and its 10-hydroxy metabolite.
    Dickinson RG; Hooper WD; Dunstan PR; Eadie MJ
    Eur J Clin Pharmacol; 1989; 37(1):69-74. PubMed ID: 2591466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical pharmacokinetics of antiepileptic drugs in paediatric patients. Part II. Phenytoin, carbamazepine, sulthiame, lamotrigine, vigabatrin, oxcarbazepine and felbamate.
    Battino D; Estienne M; Avanzini G
    Clin Pharmacokinet; 1995 Nov; 29(5):341-69. PubMed ID: 8582119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.